EFFICIENCY AT EVERY STAGE OF THE REGULATORY INFORMATION LIFECYCLE.
Integrated global standards require an integrated solution. LIQUENT puts all your critical registration and submission documentations in a centralized location—from product details and change control to tracking, documents, and submissions—allowing your team to more effectively manage product registrations, dossiers, documents and crucial operational systems over time.
Our community provides you with access to our online support facility known as Epicor CtelNet and an extensive technical knowledge base of White Papers, Documentation, Alerts, Release Notes, discussion groups and more!
THE RESULT?
- CTD and eCTD, submission activities are more integrated than ever before.
- Team-wide integration vastly improves collaboration and reduces regulatory cycle time.
- A Web-based SaaS model provides a shared user environment and minimizes reliance on IT resources.
- Built upon efficient, comprehensive process, outsourcing services allow you to move quicker and cost effectively than ever before.
- Time-to-market is significantly reduced.
ABOUT US
Balancing the needs of your product development and business development teams while getting your product launched on time can be challenging. The expert services team at LIQUENT provides you with a comprehensive portfolio of LIQUENT Regulatory Software to help you build successful, on-time submissions, and LIQUENT Outsourcing to ensure your message is on-target and scientifically literate. From submission lifecycle consulting to leading-edge content development services, we'll help you to streamline your processes, better position your organization and your products, and keep your projects moving forward.
ABOUT LIQUENT
LIQUENT regulatory solutions provide software and related regulatory and clinical services for the life sciences industry. These solutions and services help ensure clients meet the strict standards of regulatory authorities across the world helping them achieve quality, accuracy, and data integrity to deliver regulatory reports and submissions reliably and on time.
As a result, global life sciences companies, small tier to large tier, rely on LIQUENT regulatory solutions to provide the technology and services to compress the regulatory submissions and approval process, improving speed to market, cost control, and productivity, all of which contribute to ensuring patients’ and physicians’ timely access to new drugs. Over the last decade, thousands of regulatory submissions have been produced using LIQUENT world-class products and expert services.
LIQUENT is owned by Marlin Equity Partners
ABOUT MARLIN EQUITY PARTNERS
Marlin Equity Partners is a Los Angeles, California-based private investment firm with over $1 billion of capital under management. The firm is focused on providing corporate parents, shareholders and other stakeholders with tailored solutions that meet their business and liquidity needs in special situations. Marlin invests in businesses across multiple industries that are in the process of undergoing varying degrees of operational, financial or market-driven change where its capital base, industry relationships and extensive network of operational resources significantly strengthens a company's outlook and enhances value. Since its inception, Marlin, through its group of funds and related companies, has successfully completed over 30 acquisitions. For more information, please visit www.marlinequity.com.